News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Alper Topal: The Keynote 921 study failed for CRPC
Alper Topal/researchgate.net
Mar 18, 2025, 12:35

Alper Topal: The Keynote 921 study failed for CRPC

Alper Topal, Medical Onoclogist at Gülhane Training and Research Hospital, shared a paper Daniel P. Petrylak and colleagues authored on X:

“The Keynote 921 study failed for CRPC.

mPFS was 8.6 months in the pembro arm compared to 8.3 months in the placebo arm.mOS was 19.6 months in the pembro arm compared to 19 months in the placebo arm. Grade 3≥side effects were more common in the pembro arm.”

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial

Authors: Daniel P. Petrylak et al.

Alper Topal

Alper Topal Andrew J. Armstrong Andries M. Bergman cancer Charles Schloss Christian H. Poehlein Daniel P. Petrylak Eric Levesque Ernesto Korbenfeld Gero Kramer Howard Gurney Karim Fizazi Loic Mourey Margitta Retz Maria De Santis Meital Levartovsky Nobuaki Matsubara OncoDaily Oncology Pawel Zalewski Raffaele Ratta Ray Manneh Ray McDermott Russell Pachynski Rustem Gafanov Seok Soo Byun Sergio Bracarda Tilman Todenhofer Winald Gerritsen Xin Tong Li
Special Coverage
Voices
Aug 14, 2025, 18:31
Jia (Jenny) Liu: Wonderful Talks by Ecaterina Dumbrava at MOGA25 on Drug Development
Voices
Aug 14, 2025, 18:18
Michael Jefford: Great to Present ePROs Work from Julia Lai-Kwon’s PhD at MOGA25 ASM
Voices
Aug 14, 2025, 17:56
Leading with Humanity: The Humanitarian PACT - The Max Foundation
Voices
Aug 14, 2025, 17:38
Shane Jacobson Leads the American Cancer Society into a New Era of Cancer Advocacy and Care
Voices
Aug 14, 2025, 17:30
Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding
Career Updates
Aug 14, 2025, 17:20
Namrata Singh Has Been Promoted to Technical Director of the Core Pathology Lab at Dana-Farber
Career Updates
Aug 14, 2025, 17:07
Loredana Vecchionen Begins Role as Hematologist, Oncologist, and Clinician Scientist at Charité
Voices
Aug 14, 2025, 16:54
Nicholas DeVito: Looking For a Crash Course in Tumor Immunology and Immunotherapy?
Science
Aug 14, 2025, 16:44
Drew Moghanaki: The Results from the Phase 3 HARMONi Trial Will be Presented at WCLC25
Science
Aug 14, 2025, 16:27
Study Lead by Jordan Gauthier Finds How ICIs Affect CAR T-Cell Function and the TME in PMBCL
Voices
Aug 14, 2025, 16:19
Registration is Open for the 67th ASH Annual Meeting and Exposition - The American Society of Hematology
Insight
Aug 14, 2025, 16:16
Memorial Sloan Kettering Cancer Center Oncologists Co-Lead Study on KRAS-Targeted Cancer Vaccine